CLINICAL_TRIALS
trial_result
· 2021-09-09
Clinical Trial Update: A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL [Phase 3]
Summary
Phase 3 trial for Marqibo in adults 60+ with newly diagnosed acute lymphoblastic leukemia was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Acute Lymphoblastic Leukemia (ALL) | Phase 3 | Status: TERMINATED | Results posted: 2021-09-09